Skip to content

The effect fo MGD in corneal refractive surgery and patients with dry eye.

The effect of MGD in corneal refractive surgery and patients with dry eye.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027229
Enrollment
Unknown
Registered
2019-11-05
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian Gland Dysfunction

Interventions

1:Treatment for MGD
2:Untreatment for MGD

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. The wearing of soft contact lenses is stopped for more than 2 weeks and the wearing of hard contact lenses is stopped for more than 1 month; 3. The thickness of the central cornea is more than 500 µ m; the subjective refractive index is less than - 10.00d and the columnar index is 0.00-3.00d; 4. The refractive index is stable for more than 2 years; the non-contact intraocular pressure measurement is less than 21mmhg; 5. The main complaints are as follows: Dry eye symptoms, osdi score of total symptoms of each eye >= 13 points or speed score >= 6 points ; 6. Palpebral margin change: normal or mild congestion, with fat cap formation; palpebral margin becomes blunt, thickened, with palpebral gland mouth obstruction and bulge; 7. Palpebral gland compression test: lipid secretion score of 15 lower eyelid gland glands of no eye( Mgyls = 12 points (range 0-45 points); 8. Lipid layer thickness <= 60 µ m; 9. Meibomian gland imaging: lower meibomian gland loss <= 30% ~ 50%;

Exclusion criteria

Exclusion criteria: 1. Corneal pannus, corneal nebual or obvious pannus; 2. Corneal topography abnormality, suspected or confirmed keratoconus; 3. Eyelid deformity, such as entropion and trichiasis, ectropion, moderate and severe ptosis, and incomplete closure of eyelid; 4. Lack of watery dry eyes; 5. Active ocular surface, eyelid margin infection or inflammatory reaction; 6. 3 months of chronic , history of recurrent ocular inflammation; 7. 3-month history of ocular surgery, ocular trauma; 8. Systemic diseases, such as diabetes, autoimmune diseases; 9. Mental diseases, such as anxiety, depression.

Design outcomes

Primary

MeasureTime frame
Ocular Surface Disease Index;Lipid layer thickness;Meibography;Meibomian Gland Expression;Tear Inflammatory Cytokines;Tear film breakup time;Schirmer's test;

Countries

China

Contacts

Public ContactYan Wang

Tianjin Eye Hospital

wangyan7143@vip.sina.com+86 13602089393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026